文献速递关节外科

全膝关节置换术前血小板减少与假体周围关节感染风险:倾向匹配队列研究

Preoperative Thrombocytopenia and Risk of Periprosthetic Joint Infection After Total Knee Arthroplasty: A Propensity-Matched Cohort Study.
PubMed 文献 · J Arthroplasty · 2026-01-08

基于大型国家数据库的回顾性队列研究纳入2015至2023年行初次全膝关节置换术的182,043例患者,按术前血小板计数分层。调整混杂后,血小板计数越低,术后一年假体周围关节感染风险呈阶梯式升高,但浅表手术部位感染无显著关联。作者认为血小板计数与功能可能是被低估且潜在可干预的关节置换感染危险因素。

要点

  • 术前血小板100,000至149,000/μL者假体周围关节感染风险升高(OR 1.42)。
  • 血小板50,000至99,000/μL者OR 3.67,≤50,000/μL者OR 5.12,趋势P<0.001。
  • 各阈值下血小板计数与浅表手术部位感染均无显著关联。

核心结论

  • 术前血小板减少与全膝关节置换术后假体周围关节感染风险呈强且递进的相关,但与浅表手术部位感染无关。
  • 作者认为血小板在假体周围空间作为免疫效应细胞发挥作用,血小板计数与功能是被低估且潜在可干预的关节置换感染危险因素。
  • 作者指出需要前瞻性研究来确定优化血小板水平能否降低假体周围关节感染风险。

研究设计与样本

  • 回顾性队列研究,使用大型国家数据库识别2015至2023年行初次全膝关节置换术的患者。
  • 按术前血小板计数分为≤50,000/μL、50,000至99,000/μL、100,000至149,000/μL和≥150,000/μL四层。
  • 主要终点为一年内假体周围关节感染,次要终点为浅表手术部位感染;采用多变量逻辑回归和倾向评分匹配调整人口学与合并症。
  • 共纳入182,043例患者,其中8,380例(4.6%)血小板计数低于150,000/μL。
  • 证据等级为III级。

主要发现

  • 调整模型中,以血小板≥150,000/μL为参照,假体周围关节感染风险随血小板降低呈阶梯式升高:100,000至149,000/μL组OR 1.42(95%CI 1.15至1.73),50,000至99,000/μL组OR 3.67(95%CI 2.57至5.10),≤50,000/μL组OR 5.12(95%CI 1.73至12.19),趋势P<0.001。
  • 所有模型中各阈值下血小板计数与浅表手术部位感染均无显著关联。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出需要前瞻性研究来确定优化血小板水平能否降低假体周围关节感染风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Periprosthetic joint infection (PJI) remains one of the most devastating complications following total joint arthroplasty. While platelets are recognized for their role in hemostasis, growing evidence suggests they also serve as immune effectors. Experimental data support a link between platelet depletion and infection risk, yet clinical evidence is limited. METHODS: We performed a retrospective cohort study using a large national database to identify patients undergoing primary total knee arthroplasty between 2015 and 2023. Patients were stratified by preoperative platelet count: ≤ 50,000/μL, 50,000 to 99,000/μL, 100,000 to 149,000/μL, and ≥ 150,000/μL. The primary endpoint was PJI within one year, and the secondary endpoint was superficial surgical site infection (SSI). Multivariable logistic regressions and propensity score matching were used to adjust for demographics and comorbidities. Of 182,043 patients included in the study, 8,380 (4.6%) had platelet counts less than 150,000/μL. RESULTS: In adjusted models, risk of PJI increased stepwise with lower platelet counts: odds ratio (OR) 1.42 (95% confidence interval [CI]: 1.15 to 1.73) for 100,000 to 149,000/μL, OR 3.67 (95% CI: 2.57 to 5.10) for 50,000 to 99,000/μL, and OR 5.12 (95% CI: 1.73 to 12.19) for ≤ 50,000/μL compared with ≥150,000/μL (P-value trend < 0.001). Platelet count was not significantly associated with SSI at any threshold in all models. CONCLUSIONS: Preoperative thrombocytopenia is strongly and progressively associated with increased risk of PJI, but not SSI, after total knee arthroplasty. These results highlight the role of platelets as immune effectors in the periprosthetic space and suggest platelet count and function as underrecognized, potentially modifiable risk factors for arthroplasty infection. Prospective studies are needed to determine whether optimization of platelet levels can reduce PJI risk. LEVEL OF EVIDENCE: III.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Wiener JM, Hamad CD, Chun RF, et al. Preoperative Thrombocytopenia and Risk of Periprosthetic Joint Infection After Total Knee Arthroplasty: A Propensity-Matched Cohort Study. J Arthroplasty. 2026. PMID: 41519494. doi:10.1016/j.arth.2026.01.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。